Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMRN | Amarin Corporation Plc Sponsored ADR | 4.92% | 15.15 | 1.8% | $165.06m | |
| VRX | Valeant Pharmaceuticals International, Inc. | 2.01% | 21.30 | 14.1% | $125.33m | |
| GWPH | GW Pharmaceuticals PLC Sponsored ADR | 0.83% | 154.19 | 6.2% | $81.03m | |
| PRGO | Perrigo Co. Plc | 1.05% | 46.15 | 6.8% | $70.07m | |
| SAGE | SAGE Therapeutics, Inc. | 0.60% | 162.00 | 8.6% | $61.94m | |
| JAZZ | Jazz Pharmaceuticals Plc | 2.62% | 134.83 | 2.3% | $54.72m | |
| HZNP | Horizon Pharma plc | 0.60% | 27.00 | 6.7% | $46.88m | |
| UTHR | United Therapeutics Corporation | 2.33% | 81.37 | 14.3% | $44.61m | |
| PTLA | Portola Pharmaceuticals, Inc. | -0.36% | 30.41 | 7.5% | $42.98m | |
| ICLR | ICON Plc | 1.32% | 157.17 | 4.1% | $40.19m | |
| ICPT | Intercept Pharmaceuticals, Inc. | -0.99% | 64.00 | 17.2% | $38.64m | |
| CTLT | Catalent Inc | 1.10% | 55.88 | 2.4% | $35.42m | |
| MDCO | Medicines Company | 3.78% | 32.71 | 20.3% | $33.51m | |
| AERI | Aerie Pharmaceuticals, Inc. | -5.62% | 23.19 | 6.8% | $25.01m | |
| PCRX | Pacira Pharmaceuticals, Inc. | -1.85% | 38.22 | 10.5% | $24.00m |
Company Profile
MEI Pharma, Inc. engages in the clinical development of novel therapies for cancer. Its drug candidates includes Pracinostat, an oral HDAC inhibitor that is being developed in combination with azacitidine for the treatment of acute myeloid leukemia and myelodysplastic syndrome. Its pipeline also consists of ME-401, a highly selective, oral PI3K delta inhibitor; voruciclib, an oral, selective CDK inhibitor; and ME-344, a novel mitochondrial inhibitor. The company was founded on December 1, 2000 and is headquartered in San Diego, CA.